IL27 and neuroblastoma: An early report showed that murine neuroblastoma cells engineered to express IL-27 showed delayed tumor formation in syngeneic mice and showed increased MHC class I in the tumor environment due to indirect, IFN-γ-mediated, or possibly direct effects of IL-27 [42].